In addition, studies in mouse models of pulmonary fibrosis indicate that inhibition of mitogen activated protein kinases (MAPK) and/or phosphatidylinositide 3-kinase (PI3K) pathways attenuates the development of lung fibrosis [14,15]. Here, WNK2 is linked to pulmonary fibrosis.